EXHIBIT 99.1

                          BIOMED REALTY TRUST APPOINTS
                     FORMER HOME DEPOT DIRECTOR TO ITS BOARD

      SAN DIEGO, CA - JANUARY 12, 2005 - BioMed Realty Trust, Inc. (NYSE:BMR)
today announced the appointment of M. Faye Wilson to its board of directors,
increasing the board to seven members.

      "Faye's extensive background and experience in business management,
strategic planning and corporate governance will be especially valuable as
BioMed continues its growth and expansion within the life science real estate
market. We are delighted that Faye has agreed to serve on our board and look
forward to her contributions and counsel," said Alan D. Gold, president and
chief executive officer of BioMed Realty Trust.

      Wilson has served as a principal of Wilson Boyles and Company, a business
management and strategic planning consulting firm, since 2003. She served on the
board of directors of Farmers Insurance Group from 1993 through 2001 and the
board of directors of Home Depot (NYSE: HD) from 1992 through 2001. Wilson was
also a senior officer of Home Depot from 1998 through 2002. From 1992 until
1998, she served in several senior management roles at Bank of America,
including chairman of Security Pacific Financial Services and executive vice
president and chief credit officer for Bank of America's National Consumer
Banking Group. She currently serves on the board of directors of Community
Bancorp, Inc., the parent company of Community National Bank. She earned her
Masters Degrees in International Relations and Business Administration from the
University of Southern California and an undergraduate degree from Duke
University. She became a certified public accountant in 1961.

ABOUT BIOMED REALTY TRUST

      BioMed Realty Trust, Inc. is a real estate investment trust focused on
acquiring, owning, leasing, managing and selectively developing laboratory and
office space for lease to life science tenants. Tenants include biotechnology
and pharmaceutical companies, scientific research institutions, government
agencies, physician groups and other entities involved in the life science
industry. The company targets properties located in markets with established
reputations as centers for scientific research, including San Diego, San
Francisco, Seattle, Maryland, Pennsylvania, New York/New Jersey and Boston.
Additional information is available at www.biomedrealty.com.

This press release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 based on current expectations,
forecasts and assumptions that involve risks and uncertainties that could cause
actual outcomes and results to differ materially. These risks and uncertainties
include general risks affecting the real estate industry (including, without
limitation, the inability to enter into or renew leases, dependence on tenants'
financial condition, and competition from other developers, owners and operators
of real estate); adverse economic or real estate developments in the



life science industry or the California region; risks associated with the
availability and terms of financing and the use of debt to fund acquisitions and
developments; failure to manage effectively the Company's growth and expansion
into new markets, or to complete or integrate acquisitions successfully; risks
and uncertainties affecting property development and construction; risks
associated with downturns in the national and local economies, increases in
interest rates, and volatility in the securities markets; potential liability
for uninsured losses and environmental contamination; risks associated with the
Company's potential failure to qualify as a REIT under the Internal Revenue Code
of 1986, as amended, and possible adverse changes in tax and environmental laws;
and risks associated with the Company's dependence on key personnel whose
continued service is not guaranteed. For a further list and description of such
risks and uncertainties, see the reports filed by the Company with the
Securities and Exchange Commission. The Company disclaims any intention or
obligation to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.

                                      # # #